OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
Total income of €83.4 million. Cash level of €64.2 million1 as of December 31, 2024, ensuring financial visibility until Q1 2027 Three strategic agreements signed: licensing and collaboration with AbbVie ( worth up to $713 million ) , and anti-SIRPα program expansions ( worth up to €1.1 billion ) ...
OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update Total income of €83.4 million. Cash level of €64.2 million1 as of December 31, 2024, ensuring financial visibility until Q1 2027
Introducing 'Between a Rocket and a Hard Space': the ISS National Lab's New Podcast Exploring the Future of Space Innovation
KENNEDY SPACE CENTER, Fla., March 26, 2025 /PRNewswire/ -- The International Space Station ( ISS ) National Laboratory is launching a bold new way to bring the excitement of space-based research down to Earth-introducing Between a Rocket and a Hard Space, the official ISS National Lab podcast.
FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumors - Exelixis ( NASDAQ:EXEL )
FDA approves Exelixis' Cabometyx for advanced neuroendocrine tumors before the April 3 action date, expanding its previous five approvals. Phase 3 trial data shows Cabometyx plus Opdivo sustains long-term survival benefits in advanced renal cell carcinoma after 67.6 months.
PIMCO Names Janet Yellen and Raghuram Rajan to its Global Advisory Board ( GAB ) ; Gordon Brown Becomes Chair
Janet Yellen served as Treasury Secretary in the Biden Administration and Chair of the Federal Reserve from 2014 to 2018 Raghuram Rajan served as the Governor of the Reserve Bank of India and as Chief Economist at the International Monetary Fund Gordon Brown, former UK Prime Minister, becomes ...
Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer - Leap Therapeutics ( NASDAQ:LPTX )
In MSS colorectal cancer, sirexatamab's combo therapy showed a 32% higher ORR, 3.5-month longer PFS in high DKK1 patients vs. control. Patients without prior anti-VEGF therapy saw a 22% higher ORR and 2.6-month longer PFS with sirexatamab vs. control. Pelosi's latest AI pick skyrocketed 169% in ...
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Geron Corporation ( GERN ) Shareholders - Geron ( NASDAQ:GERN )
NEW YORK, March 26, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Geron Corporation GERN. Shareholders who purchased shares of GERN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Visionary Holdings Launches New Fund In Hong Kong To Propel New Energy Vehicle Industry: Details - Visionary Holdings ( NASDAQ:GV )
The issuance scale of Visionary Industrial Development LPF ( Phase I ) is $50 million. Visionary to collaborate with global institutions on investments. Feel unsure about the market's next move? Copy trade alerts from Matt Maley-a Wall Street veteran who consistently finds profits in ...
Ready Capital Corporation Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights - RC - Ready Capital ( NYSE:RC )
NEW YORK, March 26, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Ready Capital Corporation RC. Shareholders who purchased shares of RC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...




